Dogs: Contraindication: Do not administer this product orally. Do not use Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution (containing 2.5% moxidectin) on cats. For the first 30 minutes after application: Ensure that dogs cannot lick the product from application sites on themselves or other treated dogs, and separate treated dogs from one another and from other pets to reduce the risk of accidental ingestion.

Ingestion of this product by dogs may cause serious adverse reactions including depression, salivation, dilated pupils, incoordination, panting and generalized muscle tremors. In avermectin-sensitive dogs, the signs may be more severe and may include coma and death. Reduce the risk of accidental oral ingestion by separating treated pets for 30 minutes.

Cats: Avoid oral ingestion. Oral ingestion by cats may result in hypersalivation, tremors, vomiting, and decreased appetite.

Children should not contact application site for two hours on dogs or (30) thirty minutes on cats.

Dogs: Contraindication: Do not administer this product orally. Do not use Advantage Multi® for Dogs (imidacloprid + moxidectin) Topical Solution (containing 2.5% moxidectin) on cats. For the first 30 minutes after application: Ensure that dogs cannot lick the product from application sites on themselves or other treated dogs, and separate treated dogs from one another and from other pets to reduce the risk of accidental ingestion.

Ingestion of this product by dogs may cause serious adverse reactions including depression, salivation, dilated pupils, incoordination, panting and generalized muscle tremors. In avermectin-sensitive dogs, the signs may be more severe and may include coma and death. Reduce the risk of accidental oral ingestion by separating treated pets for 30 minutes.

Cats: Avoid oral ingestion. Oral ingestion by cats may result in hypersalivation, tremors, vomiting, and decreased appetite.

Children should not contact application site for two hours on dogs or (30) thirty minutes on cats.